Vision-Sciences, Inc. (VSCI) Appoints Howard Zauberman New CEO
5/14/2013 7:14:37 AM
More...
|
Vision-Sciences, Inc. (VSCI) Reports Net Sales of $4.0 Million for Third Quarter of Fiscal 2013
1/29/2013 9:28:40 AM
More...
|
Vision-Sciences, Inc. (VSCI) to Present at Lazard Capital Markets 9th Annual Healthcare Conference
11/8/2012 9:18:09 AM
More...
|
Vision-Sciences, Inc. (VSCI) Reports Net Sales of $3.7 Million for Second Quarter of Fiscal 2013
11/6/2012 9:48:16 AM
More...
|
Vision-Sciences, Inc. (VSCI) Reschedules Release Date of Second Quarter of Fiscal 2013 Results Due to Expected Severe Weather Conditions
10/29/2012 8:45:21 AM
More...
|
Vision-Sciences, Inc. (VSCI) Announces Release Date of Second Quarter of Fiscal 2013 Results
10/22/2012 9:19:52 AM
More...
|
Research Study Results Demonstrate Advantages of Vision-Sciences, Inc. (VSCI)' EndoSheath® Technology for Bronchoscopy
8/1/2012 9:27:54 AM
More...
|
Vision-Sciences, Inc. (VSCI) Reports Revenues of $3.4 Million for First Quarter 2013
7/26/2012 9:42:52 AM
More...
|
Vision-Sciences, Inc. (VSCI) Announces Release Date of First Quarter of Fiscal 2013 Results
7/24/2012 9:28:08 AM
More...
|
Vision-Sciences, Inc. (VSCI) Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease
5/18/2012 10:05:01 AM
More...
|
|